Bacto TC Yeastolate is an animal origin-free hydrolysate from the water-soluble portion of autolyzed yeast. This supplement contains a mixtureRead more
Have Questions?
Change view
Catalog Number
Quantity
255772
100 g
255771
10 kg
2 Options
Catalog number 255772
Price (USD)
77.50
Each
-
Add to cart
Quantity:
100 g
Price (USD)
77.50
Each
Add to cart
Ask our AI about this Product
Bacto TC Yeastolate is an animal origin-free hydrolysate from the water-soluble portion of autolyzed yeast. This supplement contains a mixture of peptides, amino acids, carbohydrates (simple and complex), nucleosides, and vitamins. Derived from the same yeast strain as Difco TC Yeastolate, ultra-filtered (UF), this product has a slightly different nutritional profile because it was not ultra-filtered. Bacto TC Yeastolate should be considered a suitable alternative to Difco TC Yeastolate, ultra-filtered (UF), for supplementing a variety of CHO-based applications.
Customers have used this supplement for CHO-based production of biotherapeutic monoclonal antibodies used in oncological and rheumatological therapeutics and recombinant proteins. Additionally, customers have used this supplement in combination with a soy supplement, such as Difco Phytone, ultra-filtered (UF), to provide an optimal titer performance in mammalian cell based processes by providing additional vitamins and carbohydrates.
Specifications
Cell TypeBacteria
Product LineBacto™
Quantity100 g
SourceAnimal origin-free
Product TypeTC Yeastolate
Unit SizeEach
Contents & Storage
Storage conditions: 2°C to 25°C. Store in cool, dry conditions in well-sealed containers.
Have questions about this product? Ask our AI assisted search.
Generating response
This is an AI-powered search and may not always get things right. You can help us make it better with a thumbs up or down on individual answers or by selecting the “Give feedback" button. Your search history and customer login information may be retained by Thermo Fisher and processed in accordance with our
Privacy Notice.
Los clientes que vieron este artículo también vieron